Bhudev C Das
Overview
Explore the profile of Bhudev C Das including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
2215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar P, Gupta S, Das B
Transl Oncol
. 2023 Dec;
40:101827.
PMID: 38042138
Head and neck squamous cell carcinomas (HNSCCs) are the most devastating diseases in India and southeast Asia. It is a preventable and curable disease if detected early. Tobacco and alcohol...
2.
Rana A, Adhikary M, Singh P, Das B, Bhatnagar S
Front Chem
. 2023 Jan;
10:1095598.
PMID: 36688039
Chemotherapy is the mainstay of cancer treatment today. Chemotherapeutic drugs are non-selective and can harm both cancer and healthy cells, causing a variety of adverse effects such as lack of...
3.
Mukherjee Das A, Gogia A, Garg M, Elaiyaraja A, Arambam P, Mathur S, et al.
Cancer Epidemiol
. 2022 Jun;
79:102188.
PMID: 35688051
Background: Phthalates are known endocrine-disrupting chemicals used indiscriminately as constituents in consumer products including food processing, and packaging, cosmetics, personal care and household items. Although, few studies have assessed the...
4.
Cui Z, Liu H, Zhang H, Huang Z, Tian R, Li L, et al.
Mol Ther Nucleic Acids
. 2021 Dec;
26:1466-1478.
PMID: 34938601
Zinc-finger nucleases (ZFNs), transcription activator-like endonucleases (TALENs), and CRISPR-associated Cas9 endonucleases are three major generations of genome editing tools. However, no parallel comparison about the efficiencies and off-target activity of...
5.
Kirtonia A, Ashrafizadeh M, Zarrabi A, Hushmandi K, Zabolian A, Bejandi A, et al.
J Cell Physiol
. 2021 Sep;
237(1):450-465.
PMID: 34569616
Acute myeloid leukemia (AML) is a common hematological disorder with heterogeneous nature that resulted from blocked myeloid differentiation and an enhanced number of immature myeloid progenitors. During several decades, different...
6.
Merarchi M, Dudha N, Das B, Garg M
Phytother Res
. 2021 Jun;
35(10):5384-5396.
PMID: 34132421
The current pandemic responsible for the crippling of the health care system is caused by the novel SARS-CoV-2 in 2019 and leading to coronavirus disease 2019 (COVID-19). The virus enters...
7.
Fan W, Yu M, Wang X, Xie W, Tian R, Cui Z, et al.
Cancer Gene Ther
. 2021 Jun;
29(6):758-769.
PMID: 34112918
Genome editing tools targeting high-risk human papillomavirus (HPV) oncogene could be a promising therapeutic strategy for the treatment of HPV-related cervical cancer. We aimed to improve the editing efficiency and...
8.
Khan A, Das B, Abiha U, Sisodiya S, Chikara A, Nazir S, et al.
Semin Cancer Biol
. 2021 Jun;
86(Pt 3):583-589.
PMID: 34087416
The persistent infection of high-risk Human papillomavirus (HR-HPV) induced cervical cancer remains a challenge in women worldwide including India. Recent advances in cancer research have paved the way for advanced...
9.
Aftab M, Poojary S, Seshan V, Kumar S, Agarwal P, Tandon S, et al.
Sci Rep
. 2021 May;
11(1):10323.
PMID: 33990639
MicroRNAs as cancer biomarkers in serum, plasma, and other body fluids are often used but analysis of miRNA in urine is limited. We investigated the expression of selected miRNAs in...
10.
Mukherjee Das A, Das B
Lancet Diabetes Endocrinol
. 2021 Mar;
9(5):255.
PMID: 33770514
No abstract available.